AZ Demonstrates Commitment to Patients at San Antonio Breast Cancer Symposium


Meredith Hemler

This week, a global team of AstraZeneca employees will come together in Texas for the annual San Antonio Breast Cancer Symposium (SABCS), joining approximately 7,500 attendees from more than 90 countries for the opportunity to hear and present state-of-the-art information on the prevention, diagnosis, and treatment of breast cancer and breast disease.

At SABCS, AstraZeneca will be presenting studies around breast cancer treatment research, including updated results from a previously reported investigational Phase II study that supports the safety and efficacy of an approved AstraZeneca product. SABCS 2014 will showcase our growing portfolio across breast cancer stages and types with a primary focus on advanced breast cancer, an area with a still high unmet need.

“For more than 40 years, we have been developing drugs that have significantly increased treatment options for cancer patients around the world,” said Antoine Yver, Head Oncology, Global Medicines Development at AstraZeneca. “It is a legacy we are building on within our portfolio, which we believe has the potential to redefine the treatment paradigm for cancer.”

While advances in treatment and detection have been made over the years, breast cancer remains the leading cause of cancer death in women around the world and the second leading cause of cancer deaths among U.S. women. Approximately 30% of women with early breast cancer will develop advanced or metastatic disease.

Several photos submitted by women with #MBCStrength were shown October 13 on a Times Square billboard.

We at AstraZeneca believe it is important to continue to study and evaluate treatment options for metastatic breast cancer and remain committed to developing and optimizing breast cancer therapies for all patient groups. We also believe it is critical to support those living with the disease today. An estimated 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. That’s why AstraZeneca recently launched a nationwide photo-sharing campaign to provide women living with advanced breast cancer another way to share their inspiration, experiences and strengths with others. To show their support, more than 350 women living with metastatic breast cancer uploaded photos of themselves on social media using the campaign hashtag #MBCStrength, and some of these photos were shown October 13 on a Times Square billboard to celebrate the fifth anniversary of Metastatic Breast Cancer Awareness Day.

 We are also continuing to expand our educational resources available at, a year-round resource for women living with metastatic breast cancer and their supporters.

We look forward to engaging in meaningful dialogue at SABCS with some of the world’s most inspirational leaders in breast cancer.